[HTML][HTML] Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
G Schernthaner, N Shehadeh, AS Ametov… - Cardiovascular …, 2020 - Springer
The disclosure of proven cardiorenal benefits with certain antidiabetic agents was supposed
to herald a new era in the management of type 2 diabetes (T2D), especially for the many …
to herald a new era in the management of type 2 diabetes (T2D), especially for the many …
Obesity in South and Southeast Asia—A new consensus on care and management
KW Tham, R Abdul Ghani, SC Cua… - Obesity …, 2023 - Wiley Online Library
Obesity is a chronic disease in which the abnormal or excessive accumulation of body fat
leads to impaired health and increased risk of mortality and chronic health complications …
leads to impaired health and increased risk of mortality and chronic health complications …
Mobile application interventions and weight loss in type 2 diabetes: a meta‐analysis
X Cai, S Qiu, D Luo, L Wang, Y Lu, M Li - Obesity, 2020 - Wiley Online Library
Objective This meta‐analysis aimed to assess the effect of mobile application (app)
interventions on weight loss in patients with type 2 diabetes. Methods Electronic databases …
interventions on weight loss in patients with type 2 diabetes. Methods Electronic databases …
[HTML][HTML] Silver Sulfadiazine Eradicates Antibiotic-Tolerant Staphylococcus aureus and Pseudomonas aeruginosa Biofilms in Patients with Infected Diabetic Foot …
EG Di Domenico, B De Angelis, I Cavallo… - Journal of Clinical …, 2020 - mdpi.com
Infections are among the most frequent and challenging events in diabetic foot ulcers
(DFUs). Pathogenic bacteria growing in biofilms within host tissue are highly tolerant to …
(DFUs). Pathogenic bacteria growing in biofilms within host tissue are highly tolerant to …
[HTML][HTML] Liraglutide effects on glycemic control and weight in patients with type 2 diabetes Mellitus: A real-world, observational study and brief narrative review
Background Glycemic control and weight gain are two essential considerations in the
pharmacological management of type 2 diabetes mellitus. Pharmacological agents are …
pharmacological management of type 2 diabetes mellitus. Pharmacological agents are …
[HTML][HTML] The Impact of Digital Self-Monitoring of Weight on Improving Diabetes Clinical Outcomes: Quasi-Randomized Study
Y Fundoiano-Hershcovitz, MD Ritholz… - Journal of Medical …, 2024 - jmir.org
Background The management of type 2 diabetes (T2D) and obesity, particularly in the
context of self-monitoring, remains a critical challenge in health care. As nearly 80% to 90 …
context of self-monitoring, remains a critical challenge in health care. As nearly 80% to 90 …
The safety and efficacy of once-weekly glucagon-like peptide-1 receptor agonist semaglutide in patients with type 2 diabetes mellitus: a systemic review and meta …
X Li, S Qie, X Wang, Y Zheng, Y Liu, G Liu - Endocrine, 2018 - Springer
Objectives To investigate the safety and efficacy of once-weekly glucagon-like peptide-1
(GLP-1) receptor agonist semaglutide as monotherapy or add-on to other …
(GLP-1) receptor agonist semaglutide as monotherapy or add-on to other …
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions
AB Di Stefano, D Massihnia, F Grisafi… - European journal of cell …, 2019 - Elsevier
Angiogenesis is a crucial process for the maintenance of normal tissue physiology and it is
involved in tissue remodeling and regeneration. This process is essential for adipose tissue …
involved in tissue remodeling and regeneration. This process is essential for adipose tissue …
[HTML][HTML] Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity
Abstract Purpose of Review Numerous observations have indicated an increased risk of
developing various types of cancers, as well as cancer-related mortality, among patients …
developing various types of cancers, as well as cancer-related mortality, among patients …
Multidisciplinary Panel Consensus for the Management of Patients with Type 2 Diabetes: A Delphi Study
AM Cebrián-Cuenca, O Moreno-Pérez… - Archives of Medical …, 2024 - Elsevier
Aim To reach a multidisciplinary consensus on managing patients with type 2 diabetes
among specialists in family medicine, cardiology, endocrinology, internal medicine, and …
among specialists in family medicine, cardiology, endocrinology, internal medicine, and …